The evolving field of biodefence: therapeutic developments and diagnostics

The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Burnett, James C., Henchal, Erik A., Schmaljohn, Alan L., Bavari, Sina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096857/
https://www.ncbi.nlm.nih.gov/pubmed/15803193
http://dx.doi.org/10.1038/nrd1694
_version_ 1783510917943656448
author Burnett, James C.
Henchal, Erik A.
Schmaljohn, Alan L.
Bavari, Sina
author_facet Burnett, James C.
Henchal, Erik A.
Schmaljohn, Alan L.
Bavari, Sina
author_sort Burnett, James C.
collection PubMed
description The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents.
format Online
Article
Text
id pubmed-7096857
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70968572020-03-26 The evolving field of biodefence: therapeutic developments and diagnostics Burnett, James C. Henchal, Erik A. Schmaljohn, Alan L. Bavari, Sina Nat Rev Drug Discov Article The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents. Nature Publishing Group UK 2005 /pmc/articles/PMC7096857/ /pubmed/15803193 http://dx.doi.org/10.1038/nrd1694 Text en © Nature Publishing Group 2005 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Burnett, James C.
Henchal, Erik A.
Schmaljohn, Alan L.
Bavari, Sina
The evolving field of biodefence: therapeutic developments and diagnostics
title The evolving field of biodefence: therapeutic developments and diagnostics
title_full The evolving field of biodefence: therapeutic developments and diagnostics
title_fullStr The evolving field of biodefence: therapeutic developments and diagnostics
title_full_unstemmed The evolving field of biodefence: therapeutic developments and diagnostics
title_short The evolving field of biodefence: therapeutic developments and diagnostics
title_sort evolving field of biodefence: therapeutic developments and diagnostics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096857/
https://www.ncbi.nlm.nih.gov/pubmed/15803193
http://dx.doi.org/10.1038/nrd1694
work_keys_str_mv AT burnettjamesc theevolvingfieldofbiodefencetherapeuticdevelopmentsanddiagnostics
AT henchalerika theevolvingfieldofbiodefencetherapeuticdevelopmentsanddiagnostics
AT schmaljohnalanl theevolvingfieldofbiodefencetherapeuticdevelopmentsanddiagnostics
AT bavarisina theevolvingfieldofbiodefencetherapeuticdevelopmentsanddiagnostics
AT burnettjamesc evolvingfieldofbiodefencetherapeuticdevelopmentsanddiagnostics
AT henchalerika evolvingfieldofbiodefencetherapeuticdevelopmentsanddiagnostics
AT schmaljohnalanl evolvingfieldofbiodefencetherapeuticdevelopmentsanddiagnostics
AT bavarisina evolvingfieldofbiodefencetherapeuticdevelopmentsanddiagnostics

Ejemplares similares